Since studies demonstrated that DDR proteins may be potentially targeted for cancer therapy (22, 23), thus, it would be important to locate a drug that can specially target RFWD3-dependent Rad51 ubiquitination for cancer therapy. Here, DDR1 is linked to cancer.